These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 32056779)

  • 1. Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes.
    Ahmed AT; MahmoudianDehkordi S; Bhattacharyya S; Arnold M; Liu D; Neavin D; Moseley MA; Thompson JW; Williams LSJ; Louie G; Skime MK; Wang L; Riva-Posse P; McDonald WM; Bobo WV; Craighead WE; Krishnan R; Weinshilboum RM; Dunlop BW; Millington DS; Rush AJ; Frye MA; Kaddurah-Daouk R;
    J Affect Disord; 2020 Mar; 264():90-97. PubMed ID: 32056779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression.
    MahmoudianDehkordi S; Ahmed AT; Bhattacharyya S; Han X; Baillie RA; Arnold M; Skime MK; John-Williams LS; Moseley MA; Thompson JW; Louie G; Riva-Posse P; Craighead WE; McDonald W; Krishnan R; Rush AJ; Frye MA; Dunlop BW; Weinshilboum RM; Kaddurah-Daouk R;
    Transl Psychiatry; 2021 Mar; 11(1):153. PubMed ID: 33654056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic profiles of 38 acylcarnitines in major depressive episodes before and after treatment.
    Ait Tayeb AEK; Colle R; Chappell K; El-Asmar K; Acquaviva-Bourdain C; David DJ; Trabado S; Chanson P; Feve B; Becquemont L; Verstuyft C; Corruble E
    Psychol Med; 2024 Jan; 54(2):289-298. PubMed ID: 37226550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreases in Circulating Concentrations of Short-Chain Acylcarnitines are Associated with Systolic Function Improvement After Decompensated Heart Failure.
    Chen WS; Liu MH; Cheng ML; Wang CH
    Int Heart J; 2020 Sep; 61(5):1014-1021. PubMed ID: 32879261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders.
    Ahmed AT; Frye MA; Rush AJ; Biernacka JM; Craighead WE; McDonald WM; Bobo WV; Riva-Posse P; Tye SJ; Mayberg HS; Hall-Flavin DK; Skime MK; Jenkins GD; Wang L; Krishnan RR; Weinshilboum RM; Kaddurah-Daouk R; Dunlop BW;
    J Affect Disord; 2018 Oct; 238():1-7. PubMed ID: 29807322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot Study of Metabolomic Clusters as State Markers of Major Depression and Outcomes to CBT Treatment.
    Bhattacharyya S; Dunlop BW; Mahmoudiandehkordi S; Ahmed AT; Louie G; Frye MA; Weinshilboum RM; Krishnan RR; Rush AJ; Mayberg HS; Craighead WE; Kaddurah-Daouk R
    Front Neurosci; 2019; 13():926. PubMed ID: 31572108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similarities in serum acylcarnitine patterns in type 1 and type 2 diabetes mellitus and in metabolic syndrome.
    Bene J; Márton M; Mohás M; Bagosi Z; Bujtor Z; Oroszlán T; Gasztonyi B; Wittmann I; Melegh B
    Ann Nutr Metab; 2013; 62(1):80-5. PubMed ID: 23296094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress.
    Spiekerkoetter U; Tokunaga C; Wendel U; Mayatepek E; Exil V; Duran M; Wijburg FA; Wanders RJ; Strauss AW
    Eur J Clin Invest; 2004 Mar; 34(3):191-6. PubMed ID: 15025677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acylcarnitine profiles in pediatric liver disease do not interfere with the diagnosis of long-chain fatty acid oxidation defects.
    Fuda F; Narayan SB; Squires RH; Bennett MJ
    Clin Chim Acta; 2006 May; 367(1-2):185-8. PubMed ID: 16414039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired acylcarnitine profile in transfusion-dependent beta-thalassemia major patients in Bangladesh.
    Kumar Sarker S; Islam MT; Sarower Bhuyan G; Sultana N; Begum MN; Al Mahmud-Un-Nabi M; Al Noman Howladar MA; Farhana Dipta T; Muraduzzaman AKM; Kashfi Qadri S; Shirin T; Sadiya S; Hussain M; Ahmed Khan W; Akhteruzzaman S; Saleheen Qadri S; Qadri F; Mannoor K
    J Adv Res; 2018 Jul; 12():55-66. PubMed ID: 30046479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective treatment in carnitine-acylcarnitine translocase deficiency.
    Pierre G; Macdonald A; Gray G; Hendriksz C; Preece MA; Chakrapani A
    J Inherit Metab Dis; 2007 Oct; 30(5):815. PubMed ID: 17508264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomic and inflammatory signatures of symptom dimensions in major depression.
    Brydges CR; Bhattacharyya S; Dehkordi SM; Milaneschi Y; Penninx B; Jansen R; Kristal BS; Han X; Arnold M; Kastenmüller G; Bekhbat M; Mayberg HS; Craighead WE; Rush AJ; Fiehn O; Dunlop BW; Kaddurah-Daouk R;
    Brain Behav Immun; 2022 May; 102():42-52. PubMed ID: 35131442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between acylcarnitine profiles in plasma and bloodspots.
    de Sain-van der Velden MG; Diekman EF; Jans JJ; van der Ham M; Prinsen BH; Visser G; Verhoeven-Duif NM
    Mol Genet Metab; 2013; 110(1-2):116-21. PubMed ID: 23639448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Allium macrostemon on a rat model of depression studied by using plasma lipid and acylcarnitine profiles from liquid chromatography/mass spectrometry.
    Chen S; Wei C; Gao P; Kong H; Jia Z; Hu C; Dai W; Wu Y; Xu G
    J Pharm Biomed Anal; 2014 Feb; 89():122-9. PubMed ID: 24284228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acylcarnitine profiles in serum and muscle of dairy cows receiving conjugated linoleic acids or a control fat supplement during early lactation.
    Yang Y; Sadri H; Prehn C; Adamski J; Rehage J; Dänicke S; Saremi B; Sauerwein H
    J Dairy Sci; 2019 Jan; 102(1):754-767. PubMed ID: 30343917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS.
    Nakajima Y; Ito T; Maeda Y; Ichiki S; Kobayashi S; Ando N; Hussein MH; Kurono Y; Sugiyama N; Togari H
    Brain Dev; 2011 Nov; 33(10):816-23. PubMed ID: 21196091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acylcarnitine profiling by low-resolution LC-MS.
    Meierhofer D
    PLoS One; 2019; 14(8):e0221342. PubMed ID: 31415665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease.
    Reuter SE; Evans AM; Faull RJ; Chace DH; Fornasini G
    Ann Clin Biochem; 2005 Sep; 42(Pt 5):387-93. PubMed ID: 16168195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and release of acylcarnitines by primary myotubes reflect the differences in fasting fat oxidation of the donors.
    Wolf M; Chen S; Zhao X; Scheler M; Irmler M; Staiger H; Beckers J; de Angelis MH; Fritsche A; Häring HU; Schleicher ED; Xu G; Lehmann R; Weigert C
    J Clin Endocrinol Metab; 2013 Jun; 98(6):E1137-42. PubMed ID: 23633211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.